{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:09:27Z","timestamp":1790395767086,"version":"4.1.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The relationship of serum human immunodeficiency virus-1 (HIV-1) RNA levels to HIV-1 RNA levels in other compartments, such as the lungs, is not well characterized. The purpose of this study was to determine the viral burden of HIV-1 in the lungs by comparing HIV-1 RNA in cell-free bronchoalveolar lavage fluid (BALF) with that in serum. Specimens were examined from 77 HIV-seropositive adults (CD4+ cell counts: 0 to 700 cells\/mm3; 48% receiving prescribed antiretroviral agents), comprising 43 asymptomatic individuals who were compared with 34 persons with active lung disease caused by Pneumocystis carinii (n = 26), bacteria (n = 3), Mycobacterium avium complex (n = 2), Nocardia sp. (n = 1), Aspergillus sp. (n = 1), or pulmonary Kaposi's sarcoma (n = 1). For serum HIV-1 RNA, the proportion of subjects with detectable levels and the mean values were similar for asymptomatic individuals and persons with active lung disease (85% versus 86%, respectively) (6.64 \u00d7 104 versus 1.81 \u00d7 105 HIV-1 RNA copies\/ml; p = 0.13). In contrast, HIV-1 RNA in BALF was more often detected (16% versus 62%; p = 0.001), and mean values were higher (1.04 \u00d7 105 versus 3.31 \u00d7 106 HIV-1 RNA copies\/ml; p = 0.032), in subjects with active lung disease than in asymptomatic subjects, independent of early or advanced clinical stages of HIV-related disease. For both study groups, HIV-1 RNA levels in BALF exceeded those in serum in 56% of cases by up to 66-fold, and did not correlate with local levels of tumor necrosis factor- \u03b1, granulocyte\u2013macrophage colony-stimulating factor, or interleukin-16. HIV-1 proviral DNA in cells from BALF was detected in up to 86% of subjects, more frequently in persons with advanced HIV disease (p = 0.0496), and often involved &amp;gt; 10% of BALF cells, but did not correlate with HIV-1 RNA detected in BALF. These data provide evidence for active HIV-1 replication in the lungs. HIV-1 replication is compartmentalized relative to serum, may be restricted, is independent of HIV-1 proviral DNA and clinical stage of HIV, and may be influenced by pulmonary disease such as P. carinii pneumonia or by other local or lung-specific factors. The lungs represent a large reservoir for HIV-1, and may present a source of persistent HIV-1 replication even during periods of apparent clinical latency of HIV-1 infection. Koziel H, Kim S, Reardon C, Li X, Garland R, Pinkston P, Kornfeld H. Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus\u2013infected persons with Pneumocystis carinii pneumonia.<\/jats:p>","DOI":"10.1164\/ajrccm.160.6.9902099","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T14:06:08Z","timestamp":1365084368000},"page":"2048-2055","source":"Crossref","is-referenced-by-count":47,"title":["Enhanced\n                    <i>In Vivo<\/i>\n                    Human Immunodeficiency Virus-1 Replication in the Lungs of Human Immunodeficiency Virus\u2013Infected Persons with\n                    <i>Pneumocystis carinii<\/i>\n                    Pneumonia"],"prefix":"10.1093","volume":"160","author":[{"given":"HENRY","family":"KOZIEL","sequence":"first","affiliation":[{"name":"Divisions of Pulmonary and Critical Care Medicine, Departments of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; and Division of Pulmonary and Critical Care, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SUE","family":"KIM","sequence":"additional","affiliation":[{"name":"Divisions of Pulmonary and Critical Care Medicine, Departments of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; and Division of Pulmonary and Critical Care, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHRISTINE","family":"REARDON","sequence":"additional","affiliation":[{"name":"Divisions of Pulmonary and Critical Care Medicine, Departments of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; and Division of Pulmonary and Critical Care, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIUHONG","family":"LI","sequence":"additional","affiliation":[{"name":"Divisions of Pulmonary and Critical Care Medicine, Departments of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; and Division of Pulmonary and Critical Care, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROBERT","family":"GARLAND","sequence":"additional","affiliation":[{"name":"Divisions of Pulmonary and Critical Care Medicine, Departments of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; and Division of Pulmonary and Critical Care, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PAULA","family":"PINKSTON","sequence":"additional","affiliation":[{"name":"Divisions of Pulmonary and Critical Care Medicine, Departments of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; and Division of Pulmonary and Critical Care, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HARDY","family":"KORNFELD","sequence":"additional","affiliation":[{"name":"Divisions of Pulmonary and Critical Care Medicine, Departments of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston; and Division of Pulmonary and Critical Care, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[1999,12,1]]},"reference":[{"key":"2026032708523506100_B1","first-page":"S1","article-title":"Advances in antiretroviral therapy and viral load monitoring.","volume":"10","author":"Hammer","year":"1996","journal-title":"AIDS"},{"key":"2026032708523506100_B2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nm0696-625","article-title":"HIV viral load markers in clinical practice.","volume":"2","author":"Saag","year":"1996","journal-title":"Nat. Med."},{"key":"2026032708523506100_B3","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.8096089","article-title":"High levels of HIV-1 plasma during all stages of infection determined by competitive PCR.","volume":"259","author":"Piatak","year":"1993","journal-title":"Science"},{"key":"2026032708523506100_B4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1126\/science.272.5265.1167","article-title":"Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.","volume":"272","author":"Mellors","year":"1996","journal-title":"Science"},{"key":"2026032708523506100_B5","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/0140-6736(92)91321-X","article-title":"HIV-1 viremia and influenza.","volume":"339","author":"Ho","year":"1992","journal-title":"Lancet"},{"key":"2026032708523506100_B6","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4049\/jimmunol.157.3.1271","article-title":"Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation.","volume":"157","author":"Goletti","year":"1996","journal-title":"J. Immunol."},{"key":"2026032708523506100_B7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/infdis\/174.2.401","article-title":"Changes in virus load markers during AIDS\u2013associated opportunistic diseases in human immunodeficiency virus-infected persons.","volume":"174","author":"Donovan","year":"1996","journal-title":"J. Infect. Dis."},{"key":"2026032708523506100_B8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0140-6736(93)91839-E","article-title":"Virion concentration in bronchoalveolar lavage fluids of HIV-infected patients.","volume":"342","author":"Lu","year":"1993","journal-title":"Lancet"},{"key":"2026032708523506100_B9","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1164\/ajrccm.155.3.9117038","article-title":"Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung.","volume":"155","author":"Nakata","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032708523506100_B10","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1126\/science.276.5320.1857","article-title":"Macrophages as a source of HIV during opportunistic infections.","volume":"276","author":"Orenstein","year":"1997","journal-title":"Science"},{"key":"2026032708523506100_B11","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1172\/JCI560","article-title":"Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation.","volume":"102","author":"Koziel","year":"1998","journal-title":"J. Clin. Invest."},{"key":"2026032708523506100_B12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1152\/jappl.1986.60.2.532","article-title":"Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.","volume":"60","author":"Rennard","year":"1986","journal-title":"J. Appl. Physiol."},{"key":"2026032708523506100_B13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1126\/science.3336784","article-title":"DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells.","volume":"239","author":"Ou","year":"1988","journal-title":"Science"},{"key":"2026032708523506100_B14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1164\/ajrccm\/144.1.195","article-title":"Alveolar macrophages from patients with AIDS and AIDS- related complex constitutively synthesize and release tumor necrosis factor-\u03b1.","volume":"144","author":"Agostini","year":"1991","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708523506100_B15","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.4049\/jimmunol.149.10.3379","article-title":"Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1-infected patients: a mechanism accounting for macrophage and neutrophil accumulation.","volume":"149","author":"Agostini","year":"1992","journal-title":"J. Immunol."},{"key":"2026032708523506100_B16","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1073\/pnas.86.15.5974","article-title":"Tumor necrosis factor-\u03b1 activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-\u03baB sites in the long terminal repeat.","volume":"86","author":"Duh","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026032708523506100_B17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/378563a0","article-title":"HIV suppression by interleukin-16.","volume":"378","author":"Baier","year":"1995","journal-title":"Nature"},{"key":"2026032708523506100_B18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4049\/jimmunol.158.1.5","article-title":"Interleukin-16 represses HIV-1 promotor activity.","volume":"158","author":"Maciaszek","year":"1997","journal-title":"J. Immunol."},{"key":"2026032708523506100_B19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/362355a0","article-title":"HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.","volume":"362","author":"Pantaleo","year":"1993","journal-title":"Nature"},{"key":"2026032708523506100_B20","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1084\/jem.187.6.949","article-title":"The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 cell proliferation: the impact of highly active antiretroviral therapy.","volume":"187","author":"Tenner-Racz","year":"1998","journal-title":"J. Exp. Med."},{"key":"2026032708523506100_B21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1164\/ajrccm\/143.4_Pt_1.850","article-title":"Frequent identification of HIV-1 DNA in bronchoalveolar lavage cells obtained from individuals with the acquired immunodeficiency syndrome.","volume":"143","author":"Rose","year":"1991","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708523506100_B22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/infdis\/169.1.18","article-title":"Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type-1-infected persons, production of cytokines, and clinical status.","volume":"169","author":"Sierra-Madero","year":"1994","journal-title":"J. Infect. Dis."},{"key":"2026032708523506100_B23","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/ajrccm\/148.5.1308","article-title":"Human immunodeficiency virus production by alveolar lymphocytes is increased during Pneumocystis carinii pneumonia.","volume":"148","author":"Israel-Biet","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708523506100_B24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/infdis\/172.3.859","article-title":"Enhanced production of human immunodeficiency virus type 1 by in vitro-infected alveolar macrophages from otherwise healthy cigarette smokers.","volume":"172","author":"Abbud","year":"1995","journal-title":"J. Infect. Dis."},{"key":"2026032708523506100_B25","first-page":"L1025","article-title":"RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages.","volume":"272","author":"Coffey","year":"1997","journal-title":"Am. J. Physiol."},{"key":"2026032708523506100_B26","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1164\/arrd.1987.135.6.1276","article-title":"Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage.","volume":"135","author":"Marcy","year":"1987","journal-title":"Am. Rev. Respir. Dis."}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/160\/6\/2048\/67430722\/ajrccm_160_6_2048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/160\/6\/2048\/67430722\/ajrccm_160_6_2048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:53:28Z","timestamp":1774616008000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/160\/6\/2048\/8529655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12,1]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1999,12,1]]},"published-print":{"date-parts":[[1999,12,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.160.6.9902099","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1999,12]]},"published":{"date-parts":[[1999,12,1]]}}}